Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.
Bernasconi-Bisio F, Molina E, Ibarra V, Ibáñez-Sala I, Rochira F, Jauregui P, Rodríguez-Diaz S, Martínez-Turrillas R, Azagra-Barber I, Gómez-Cebrián N, Lasarte JJ, Puchades-Carrasco L, Vanrell L, Rodríguez-Madoz JR, Prósper F, Pineda-Lucena A.
Bernasconi-Bisio F, et al. Among authors: vanrell l.
Mol Ther Oncol. 2025 Feb 11;33(1):200949. doi: 10.1016/j.omton.2025.200949. eCollection 2025 Mar 20.
Mol Ther Oncol. 2025.
PMID: 40084273
Free PMC article.